New drug aims to stop cancer wasting in colorectal patients
Symptom relief
Recruiting now
This study tests a drug called NGM120 in people with colorectal cancer who are losing weight due to cancer cachexia. The goal is to see if NGM120 can help patients gain or maintain weight and improve their quality of life. About 136 participants will receive either NGM120 or a pl…
Phase: PHASE2 • Sponsor: NGM Biopharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC